Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LBN MEDICAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   2.9% 2.2% 1.2% 0.9% 0.8% 0.6% 7.4% 7.4%   Credit score (0-100)   60 67 81 87 92 96 33 33   Credit rating   BBB BBB A A AA AA BBB BBB   Credit limit (kDKK)   0.0 0.4 541.9 2,437.3 3,352.1 5,002.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   23,553 28,229 33,080 43,985 44,571 47,147 0.0 0.0   EBITDA   1,011 3,639 5,533 12,080 11,298 14,186 0.0 0.0   EBIT   819 3,444 4,916 11,209 10,114 12,574 0.0 0.0   Pre-tax profit (PTP)   415.0 3,009.0 4,175.0 11,042.0 9,666.0 12,126.0 0.0 0.0   Net earnings   287.0 2,344.0 3,242.0 8,635.0 7,550.0 9,446.0 0.0 0.0   Pre-tax profit without non-rec. items   415 3,009 4,175 11,042 9,666 12,126 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   427 2,353 2,307 2,877 2,745 2,819 0.0 0.0   Shareholders equity total   5,435 7,779 9,521 16,656 24,205 33,651 27,651 27,651   Interest-bearing liabilities   8,486 3,407 3,000 360 0.0 0.0 0.0 0.0   Balance sheet total (assets)   34,615 43,669 57,230 55,308 63,537 69,776 27,651 27,651   Net Debt   8,483 1,154 -10,635 -14,914 -3,757 -7,041 -27,651 -27,651     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   23,553 28,229 33,080 43,985 44,571 47,147 0.0 0.0   Gross profit growth   -2.4% 19.9% 17.2% 33.0% 1.3% 5.8% -100.0% 0.0%   Employees   44 46 49 51 53 52 0 0   Employee growth %   0.0% 4.5% 6.5% 4.1% 3.9% -1.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   34,615 43,669 57,230 55,308 63,537 69,776 27,651 27,651   Balance sheet change%   7.2% 26.2% 31.1% -3.4% 14.9% 9.8% -60.4% 0.0%   Added value   1,011.0 3,639.0 5,533.0 12,080.0 10,985.0 14,186.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -37 1,731 -663 -301 -1,316 -1,538 -2,819 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.5% 12.2% 14.9% 25.5% 22.7% 26.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.4% 8.8% 9.7% 19.9% 17.0% 19.1% 0.0% 0.0%   ROI %   7.0% 26.1% 39.3% 76.0% 49.1% 44.0% 0.0% 0.0%   ROE %   5.4% 35.5% 37.5% 66.0% 37.0% 32.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   28.6% 22.8% 22.8% 37.3% 43.1% 55.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   839.1% 31.7% -192.2% -123.5% -33.3% -49.6% 0.0% 0.0%   Gearing %   156.1% 43.8% 31.5% 2.2% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.3% 7.3% 23.2% 10.7% 248.9% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.6 0.8 0.9 0.4 0.6 0.0 0.0   Current Ratio   1.3 1.3 1.1 1.3 1.5 1.8 0.0 0.0   Cash and cash equivalent   3.0 2,253.0 13,635.0 15,274.0 3,757.0 7,041.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   7,718.0 9,461.0 6,911.0 13,477.0 21,147.0 30,506.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   23 79 113 237 207 273 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   23 79 113 237 213 273 0 0   EBIT / employee   19 75 100 220 191 242 0 0   Net earnings / employee   7 51 66 169 142 182 0 0